Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Open Access
- 26 August 2022
- journal article
- editorial
- Published by Springer Nature in Intensive Care Research
- Vol. 3 (1) , 12-17
Abstract
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate. Supportive care is the mainstay of treatment and there is no definitive pharmacological treatment as yet. In nonclinical studies, neutrophil elastase inhibitor sivelestat appears to show benefit in ARDS without inhibiting the host immune defense in cases of infection. In clinical studies, the efficacy of sivelestat in the treatment of ARDS remains controversial. The currently available evidence suggests that sivelestat may show some benefit in the treatment of ARDS, although large, randomized controlled trials are needed in specific pathophysiological conditions to explore these potential benefits.Keywords
Funding Information
- National Natural Science Foundation of China (82160360)
This publication has 34 references indexed in Scilit:
- Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypassInteractive CardioVascular and Thoracic Surgery, 2010
- SIVELESTAT (SELECTIVE NEUTROPHIL ELASTASE INHIBITOR) IMPROVES THE MORTALITY RATE OF SEPSIS ASSOCIATED WITH BOTH ACUTE RESPIRATORY DISTRESS SYNDROME AND DISSEMINATED INTRAVASCULAR COAGULATION PATIENTSShock, 2010
- Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental studyRespiratory Research, 2009
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Relationship between neutrophil elastase and acute lung injury in humansPulmonary Pharmacology & Therapeutics, 2004
- Pilot Study of the Effects of ONO-5046 in Patients with Acute Respiratory Distress SyndromeAnesthesia & Analgesia, 2004
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Effect of Human Neutrophil Elastase on Tracheal Mucociliary Transport in Anesthetized QuailsThe Japanese Journal of Pharmacology, 1997
- Release of Interleukin-8, Interleukin-6, and Colony-stimulating Factors by Upper Airway Epithelial Cells: Implications for Cystic FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 1993
- ONO-5046, a novel inhibitor of human neutrophil elastaseBiochemical and Biophysical Research Communications, 1991